Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe history now includes a new entry: Revision: v3.4.2; the previously visible notice about government funding delays and the prior Revision: v3.4.1 have been removed.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding lapse notice at the top directing users to cc.nih.gov and opm.gov; updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedUI enhancements in the history view add a glossary display and green/red color-coded highlights to show additions and deletions. Revision notes have been updated from v3.3.4 to v3.4.0.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter updated to show Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page history now shows Revision: v3.3.2 added and Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.